Literature DB >> 9133527

Transvenous closure of secundum atrial septal defects: preliminary results with a new self-expanding nitinol prosthesis in a swine model.

M J Sharafuddin1, X Gu, J L Titus, M Urness, J J Cervera-Ceballos, K Amplatz.   

Abstract

BACKGROUND: Our purpose was to evaluate a new prosthesis for percutaneous closure of secundum atrial septal defects (ASDs). METHODS AND
RESULTS: Percutaneous closure of surgically created fossa ovalis ASD was attempted in 15 minipigs. The mean balloon-stretched ASD diameter was 12.3+/-2.3 mm (range, 10 to 16 mm). The self-expanding prosthesis was braided from 0.005-in Nitinol wires in the shape of two flat buttons with a short connecting waist with a diameter corresponding to that of the defect to be closed. Polyester filling was added to enhance thrombogenicity. Pulmonary arteriography with levo-phase was obtained before placement; immediately after placement; and at 1-week, 1-month, and 3-month follow-ups. Four animals were killed at 1 week, 1 month, and 3 months for histopathological correlation. Three deaths resulted from ventricular fibrillation (one during anesthesia and two during the placement procedure). Successful placement of the prosthesis was achieved in the remaining 12 animals. Overall immediate ASD closure on angiography occurred in 7 of 12 animals (all polyester-filled prostheses). Absent or trace shunt by angiography was present in 11 of 12 devices at 1 week, with the remaining one demonstrating a small shunt. All septal defects were completely closed at 1 month with the exception of one case in which delayed partial dislodgment of an undersized prosthesis into the right atrium had developed. Closure rate at 3 months was 100%. Neoendothelialization and fibrous incorporation of the prosthesis were completed within 1 to 3 months.
CONCLUSIONS: Effective and permanent occlusion of secundum ASDs is feasible with a device that offers the advantages of easy placement, self-centering, and repositionability.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9133527     DOI: 10.1161/01.cir.95.8.2162

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  36 in total

Review 1.  Atrial septum defect closure device in a beating heart, from the perspective of a researcher in artificial organs.

Authors:  Yasuko Tomizawa
Journal:  J Artif Organs       Date:  2012-06-23       Impact factor: 1.731

Review 2.  Closure of patent foramen ovale: technique, pitfalls, complications, and follow up.

Authors:  B Meier
Journal:  Heart       Date:  2005-04       Impact factor: 5.994

3.  Histopathological workup of an Amplatzer atrial septal defect occluder after surgical removal.

Authors:  Matthias Sigler; Christian Jux; Peter Ewert
Journal:  Pediatr Cardiol       Date:  2006-10-09       Impact factor: 1.655

4.  Transcatheter closure of atrial septal defect and interatrial communications with a new self expanding nitinol double disc device (Amplatzer septal occluder): multicentre UK experience.

Authors:  K C Chan; M J Godman; K Walsh; N Wilson; A Redington; J L Gibbs
Journal:  Heart       Date:  1999-09       Impact factor: 5.994

5.  Percutaneous closure of secundum atrial septal defect with a new self centering device ("angel wings").

Authors:  C Rickers; C Hamm; H Stern; T Hofmann; O Franzen; R Schräder; H Sievert; D Schranz; I Michel-Behnke; J Vogt; D Kececioglu; W Sebening; A Eicken; H Meyer; W Matthies; F Kleber; J Hug; J Weil
Journal:  Heart       Date:  1998-11       Impact factor: 5.994

6.  Late complications of an atrial septal occluder provoked by anticoagulant therapy.

Authors:  Uyên Châu Nguyên; Bob Weijs; Peter Luyten; Carin Blokzijl; Maarten Witsenburg; Paul G A Volders; Sebastiaan C A M Bekkers
Journal:  J Cardiol Cases       Date:  2017-11-07

7.  Amplatzer Device closure of Atrial Septal Defects and Patent Ductus Arteriosus: Initial Experience.

Authors:  J S Dugal; V Jetley; Charanjit Singh; S K Datta; J S Sabharwal; Sunil Sofat
Journal:  Med J Armed Forces India       Date:  2011-07-21

8.  Secondary residual shunt after atrial septal defect closure with an amplatzer occluder: surgical removal and evaluation of device biocompatibility after 7 years.

Authors:  Weihua Zhu; Henning Neubauer
Journal:  Pediatr Cardiol       Date:  2010-08-01       Impact factor: 1.655

Review 9.  Catheter Ablation of Atrial Fibrillation in Patients with Hardware in the Heart - Septal Closure Devices, Mechanical Valves and More.

Authors:  Stefano Bartoletti; Pasquale Santangeli; Luigi DI Biase; Andrea Natale
Journal:  J Atr Fibrillation       Date:  2013-06-30

10.  Closure of defects of the atrial septum in adults using the Amplatzer device: 100 consecutive patients in a single center.

Authors:  I F Purcell; S J Brecker; D E Ward
Journal:  Clin Cardiol       Date:  2004-09       Impact factor: 2.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.